Wikipedia
Accurin
An Accurin(tm) is a type of nanomedicine being developed by Bind Therapeutics to treat various types of cancer.
Accurins include:
- BIND-014, targeting PSMA delivering docetaxel, in phase 2 clinical trials
- BIND-510, targeting PSMA delivering vincristine. IND soon.
- BIND-2206 containing the AKT inhibitor MK-2206.